Cooper Companies, Inc. (COO) stock
COONasdaqOphthalmic GoodsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 16/3040% below fair value
$60.75+0.03 (+0.05%)
Close on Nov 18, 2026Market cap $11.55BP/E 20.7Yield –
Cooper Companies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cooper Companies's revenue for the twelve months ending Jul 31, 2026 was $4.24B, up 4.7% year over year. For fiscal 2025 it was $4.09B, up 5.1% from the year before. Over ten years it grew 8.6% a year on average. The highest annual figure on record is $4.09B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.09B | +5.1% |
| FY2024 | Oct 31, 2024 | $3.90B | +8.4% |
| FY2023 | Oct 31, 2023 | $3.59B | +8.6% |
| FY2022 | Oct 31, 2022 | $3.31B | +13.2% |
| FY2021 | Oct 31, 2021 | $2.92B | +20.2% |
| FY2020 | Oct 31, 2020 | $2.43B | -8.4% |
| FY2019 | Oct 31, 2019 | $2.65B | +4.8% |
| FY2018 | Oct 31, 2018 | $2.53B | +18.4% |
| FY2017 | Oct 31, 2017 | $2.14B | +8.8% |
| FY2016 | Oct 31, 2016 | $1.97B | +9.4% |
| FY2015 | Oct 31, 2015 | $1.80B | +4.6% |
| FY2014 | Oct 31, 2014 | $1.72B | +8.2% |
| FY2013 | Oct 31, 2013 | $1.59B | +9.9% |
| FY2012 | Oct 31, 2012 | $1.45B | +8.6% |
| FY2011 | Oct 31, 2011 | $1.33B | +14.9% |
| FY2010 | Oct 31, 2010 | $1.16B | +7.2% |
| FY2009 | Oct 31, 2009 | $1.08B | +3.2% |
| FY2008 | Oct 31, 2008 | $1.05B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $1.07B | +0.6% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $1.08B | +7.9% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $1.02B | +6.2% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $1.07B | +4.6% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $1.06B | +5.7% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $1.00B | +6.3% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $964.70M | +3.6% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $1.02B | +9.8% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $1.00B | +7.8% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $942.60M | +7.4% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $931.60M | +8.5% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $927.10M | +9.3% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $930.20M | +10.3% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $877.40M | +5.7% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $858.50M | +9.1% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $848.10M | +11.7% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $843.40M | +10.5% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $829.80M | +15.3% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $787.20M | +15.7% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $759.10M | +11.4% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $763.40M | +32.0% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $719.50M | +37.1% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $680.50M | +5.3% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $681.60M | -1.4% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $578.20M | -14.9% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $524.90M | -19.8% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $646.20M | +2.9% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $691.60M | +6.2% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $679.40M | +2.9% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $654.30M | +3.6% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $628.10M | +6.5% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $651.50M | +16.0% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $660.00M | +18.7% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $631.30M | +20.8% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $590.00M | +18.2% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $561.50M | +8.3% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $556.00M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $522.40M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $499.10M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $518.70M | – |
See a number that looks wrong?